Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 93.73% is in line with its 5-year average of 93.34%, around the middle of its 5-year range (91.79%–95.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.06% above its 12-month average of 92.75%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
93.73%
GROSS MARGIN AVG TTM
92.75%
GROSS MARGIN AVG 3Y
92.84%
GROSS MARGIN AVG 5Y
93.34%
GROSS MARGIN AVG 10Y
94.02%
GROSS MARGIN AVG 15Y
95.66%
GROSS MARGIN AVG 20Y
96.33%
CURRENT VS TTM AVG
+1.06%
CURRENT VS 3Y AVG
+0.96%
CURRENT VS 5Y AVG
+0.42%
CURRENT VS 10Y AVG
-0.31%
CURRENT VS 15Y AVG
-2.02%
CURRENT VS 20Y AVG
-2.69%
SECTOR MEDIAN · HEALTHCARE
58.69%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+59.70%
vs the sector median at left
Incyte Corporation
Market Cap
$24.28B
Gross Margin
93.73%
TTM Avg
92.75%
3Y Avg
92.84%
5Y Avg
93.34%
Market Cap
$24.72B
Gross Margin
36.77%
TTM Avg
35.27%
3Y Avg
37.10%
5Y Avg
37.60%
Market Cap
$25.74B
Gross Margin
27.85%
TTM Avg
27.30%
3Y Avg
28.39%
5Y Avg
31.16%
Market Cap
$26.03B
Gross Margin
33.15%
TTM Avg
32.39%
3Y Avg
33.17%
5Y Avg
35.04%
Market Cap
$26.07B
Gross Margin
50.78%
TTM Avg
58.60%
3Y Avg
58.69%
5Y Avg
58.45%
Market Cap
$22.03B
Gross Margin
86.58%
TTM Avg
88.58%
3Y Avg
89.63%
5Y Avg
90.66%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | $24.28B | 93.73% | 92.75% | 92.84% | 93.34% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.72B | 36.77% | 35.27% | 37.10% | 37.60% |
| BioNTech SE (BNTX)vs › | $23.16B | 73.26% | 78.98% | 81.24% | 82.89% |
| Labcorp Holdings Inc. (LH)vs › | $25.74B | 27.85% | 27.30% | 28.39% | 31.16% |
| STERIS plc (STE)vs › | $22.68B | 44.25% | 44.13% | 43.77% | 43.82% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.03B | 33.15% | 32.39% | 33.17% | 35.04% |
| Waters Corporation (WAT)vs › | $26.07B | 50.78% | 58.60% | 58.69% | 58.45% |
| Moderna, Inc. (MRNA)vs › | $22.32B | 55.35% | 54.80% | 53.09% | 65.45% |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | 86.58% | 88.58% | 89.63% | 90.66% |
| Viatris Inc. (VTRS)vs › | $20.55B | 34.40% | 36.61% | 38.73% | 36.31% |
Gross Margin
93.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 93.73% |
| 2026-03-31 | 91.79% |
| 2025-12-31 | 91.96% |
| 2025-09-30 | 92.75% |
| 2025-06-30 | 93.52% |
| 2025-03-31 | 93.05% |
| 2024-12-31 | 92.49% |
| 2024-09-30 | 92.44% |
| 2024-06-30 | 92.66% |
| 2024-03-31 | 93.08% |
| 2023-12-31 | 93.11% |
| 2023-09-30 | 93.46% |
| 2023-06-30 | 92.85% |
| 2023-03-31 | 92.98% |
| 2022-12-31 | 93.61% |
| 2022-09-30 | 93.37% |
| 2022-06-30 | 94.45% |
| 2022-03-31 | 94.19% |
| 2021-12-31 | 94.91% |
| 2021-09-30 | 95.09% |
| 2021-06-30 | 94.62% |
| 2021-03-31 | 95.17% |
| 2020-12-31 | 95.40% |
| 2020-09-30 | 94.47% |
| 2020-06-30 | 95.15% |
| 2020-03-31 | 95.20% |
| 2019-12-31 | 94.45% |
| 2019-09-30 | 94.56% |
| 2019-06-30 | 94.45% |
| 2019-03-31 | 95.46% |
| 2018-12-31 | 95.01% |
| 2018-09-30 | 94.49% |
| 2018-06-30 | 95.23% |
| 2018-03-31 | 95.26% |
| 2017-12-31 | 94.96% |
| 2017-09-30 | 94.22% |
| 2017-06-30 | 93.79% |
| 2017-03-31 | 96.14% |
| 2016-12-31 | 93.99% |
| 2016-09-30 | 92.50% |
| 2016-06-30 | 94.98% |
| 2016-03-31 | 97.72% |
| 2015-12-31 | 96.02% |
| 2015-09-30 | 95.71% |
| 2015-06-30 | 96.16% |
| 2015-03-31 | 98.13% |
| 2014-12-31 | 98.04% |
| 2014-09-30 | 99.89% |
| 2014-06-30 | 99.81% |
| 2014-03-31 | 99.81% |
| 2013-12-31 | 99.83% |
| 2013-09-30 | 99.82% |
| 2013-06-30 | 99.85% |
| 2013-03-31 | 99.79% |
| 2012-12-31 | 99.91% |
| 2012-09-30 | 99.95% |
| 2012-06-30 | 99.98% |
| 2012-03-31 | 99.97% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | 0.00% |
| 2002-12-31 | 0.00% |
| 2002-09-30 | 0.00% |
